OmegaQuant has announced the launch of an HbA1c Test, with an at-home sample collection kit.
OmegaQuant (Sioux Falls, SD) has announced the launch of an HbA1c Test, with an at-home sample collection kit. The test allows people to measure the amount of blood sugar (glucose) in the blood. When glucose builds up in the blood, it bind to a protein called hemoglobin. Therefore, testing hemoglobin A1c levels is a reliable way to determine your body’s ability to metabolize glucose. As opposed to a fasting glucose test, the HbA1c Test captures someone’s blood sugar status over a period of three months.
The optimal range of HbA1c is 4.5-5.7%, therefore a result between 5.7-6.2% would indiciate the development of prediabetes, and higher than 6.2% would indicate diabetes. Test results should be discussed with healthcare providers. The test consists of a simple finger stick and a few drops of blood.
"The HbA1c test is similar to the Omega-3 Index test in that it captures someone’s status over a period of time, in this case three months or so. This offers a more accurate picture of one’s dietary intake and could indicate that dietary or lifestyle changes are needed if their blood sugar level is not in the optimal range," said Kelly Patterson, MS, RD, LDN, CSSD, clinical nutrition educator for OmegaQuant, in a press release. "This test will truly help people measure, modify and monitor their blood sugar status."
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.